ID: ALA4244582

Max Phase: Preclinical

Molecular Formula: C13H10O5

Molecular Weight: 246.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(-c2ccc(C=O)o2)ccc1C(=O)O

Standard InChI:  InChI=1S/C13H10O5/c1-17-12-6-8(2-4-10(12)13(15)16)11-5-3-9(7-14)18-11/h2-7H,1H3,(H,15,16)

Standard InChI Key:  IQZDKOJUOMOHCJ-UHFFFAOYSA-N

Associated Targets(non-human)

Hydroxyacid oxidase 1 172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 246.22Molecular Weight (Monoisotopic): 246.0528AlogP: 2.47#Rotatable Bonds: 4
Polar Surface Area: 76.74Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.55CX Basic pKa: CX LogP: 1.81CX LogD: -1.55
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.84Np Likeness Score: -0.09

References

1. Moya-Garzón MD, Martín Higueras C, Peñalver P, Romera M, Fernandes MX, Franco-Montalbán F, Gómez-Vidal JA, Salido E, Díaz-Gavilán M..  (2018)  Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1.,  61  (16): [PMID:30028141] [10.1021/acs.jmedchem.8b00399]

Source